Ida HILMI is a Professor and Senior Consultant in Gastroenterology, University of Malaya, Kuala Lumpur, Malaysia. Prof Ida Hilmi graduated with first-class honours from the University of Glasgow in 1997. She went on to do her training in internal medicine in Oxford and obtained her Membership of the Royal Colleges of Physicians of the United Kingdom (MRCP) in 2000. She then joined the Northeast London Gastroenterology and Hepatology specialist program before returning to Malaysia in 2003. She is the current Chair of the National Hepatology and Gastroenterology Training Committee and the President for the Malaysian Society of Gastroenterology and Hepatology and the President for the Malaysian Society for IBD. Her other positions include Honorary Secretary for the Asian Education Network in IBD (IBD-AEN), Board member of the Asian Organization for Crohn’s and Colitis (AOCC) and the Malaysian lead for the IBD Emerging Nations Consortium (IBD-ENC). Her past positions include Head of the Department of Medicine, Head of Division in Gastroenterology and Hepatology and Director of Endoscopy in University of Malaya. She is currently a trustee for the Journal of Hepatology and Gastroenterology Foundation which is involved in medical research, education and training in gastroenterology and hepatology within the Asia-Pacific region. In terms of colorectal cancer screening, she is part of  the Rebung project which is involved in increasing awareness for the commonest cancers in Malaysia as well as improving access to screening and care, particularly in the lower income group. Professor Hilmi’s main area of interest is inlfammatory bowel disease (IBD) and colorectal cancer screening.

Firstly, I am Chan Chow Khuen, a researcher and lecturer from Biomedical Engineering Department, Universiti Malaya. I have graduated the PhD study from National University of Singapore with the focus on Computer Modelling and Simulation for Human Biomechanics. The current research area is artificial intelligence in biomechanics with the focus on machine learning and deep learning with the big dataset particularly with the biosignal from human. Some of the biosignals are electromyography (EMG), EEG (electroencephalogram), TCD (transcranial Doppler) and also medical images. On top of that, we develop computer algorithms for deep learning in facilitating the medical practitioners to expedite and detect abnormalities regarding to human health. Dr. Chan has interests and currently developing on the human pose estimation using portable modern technologies. 

Dr. Raja Ahsan Aftab completed his PhD and Master in Clinical Pharmacy from the Universiti Sains Malaysia (USM), Malaysia and Pharm.D  from the Riphah International University, Pakistan.  He Joined Universiti Malaya in March 2023 as a senior lecturer under department of clinical pharmacy and practice. Patient outcome research with emphasis on chronic diseases management and patient health outcome optimization are research areas where Dr Raja Ahsan Aftab's expertise revolves around. His research expertise also extends to various research domains such as epidemiology, pharmacoepidemiology, clinical trials, health economics, and digital health. To date, he has successfully supervised post graduate research students and has published a number of research high impact manuscript at prestigious journal. He is also an recipient of Taylor’s emerging research grant scheme and Industrial grant  from Santen Pharmaceuticals. He is also a proud author of peer reviewed books and book chapters. Based on his expertise he was appointed as chairperson of ethics Committee and Interprofessional education. He awarded with Exemplary meritorious academic staff award (EMAS) for his contribution on teaching innovation.